Abstract
Research continues to expand our knowledge regarding the relationship between oral contraceptive pill use and gynaecological malignancy. The combined contraceptive pill increases cervical cancer in those women who are human papillomavirus positive. Current and recent use of the pill increases breast cancer incidence but this increase tends to disappear five to ten years after the pill is stopped. Some studies have suggested that this increased incidence is only among women who have used the pill at a young age, when absolute numbers are small and where risk has disappeared as these women reach menopause. The protective effect of the pill for endometrial and ovarian cancer continues up to 20 years after stopping use. Although further data are required, low‐dose pills may have a smaller impact on breast cancer risk while continuing to protect for endometrial and ovarian cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
